Related Experiment Video

Updated: May 9, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

[Myocardial revascularization]

H Möllmann1, S Szardien, J Kempfert

  • 1Abteilung für Kardiologie, Kerckhoff-Klinik Bad Nauheim, Benekestrasse 2-8, Bad Nauheim, Germany. h.moellmann@kerckhoff-klinik.de

Herz
|July 31, 2013
PubMed

Insights

Coronary artery disease (CAD) treatment has evolved, with percutaneous coronary interventions (PCI) and surgical revascularization now offering comparable outcomes. Advances in stent technology have significantly reduced in-stent restenosis, improving patient care.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Surgery

Context:

  • Coronary artery disease (CAD) presents a significant public health challenge globally.
  • Historically, treatment options for CAD were limited to surgical revascularization or medication.
  • Percutaneous coronary interventions (PCI) have emerged as a key therapeutic modality.

Purpose:

  • To review the current treatment strategies for coronary artery disease (CAD).
  • To compare the efficacy of percutaneous coronary interventions (PCI) versus surgical revascularization.
  • To highlight advancements in stent technology and their impact on reducing in-stent restenosis.

Summary:

  • Coronary artery disease (CAD) management has advanced significantly, with both PCI and surgical revascularization demonstrating comparable effectiveness.
  • New stent materials and coatings have substantially decreased the incidence of in-stent restenosis, a previous limitation of PCI.
  • Treatment decisions are individualized, considering factors like disease extent, stenosis complexity, comorbidities, and patient health.

Impact:

  • PCI and surgical revascularization are now considered equally valuable for treating CAD.
  • Patient-specific factors and multidisciplinary
  • heart team
  • discussions are crucial for optimal treatment planning.
  • Ongoing research and technological innovations continue to improve outcomes for patients with coronary artery disease.

More Related Videos

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...